Meeting Coverage:

American Academy of Ophthalmology

AAO: 2017

Gene Therapy for Wet AMD

Show Description +

Szilárd Kiss, MD, examines gene therapy as a hot topic both in eye care and health care in general. Dr. Kiss notes the less-than-stellar results of three recent gene therapy studies for wet AMD, and he highlights important factors to consider in implementing the technique. He also discusses several promising preclinical programs and identifies an ongoing clinical trial with potential.

Posted: 11/17/2017

Up Next

Head-to-Head Trials

Pravin Dugel, MD


Who, What, Where, and When?

Arsham Sheybani, MD, Ike Ahmed, MD

An Update on GATT

Davinder Grover, MD

Who Should Perform MIGS?

Michael Patterson, DO

Hot Topic: Is Astigmatism Correction a Must?

George Waring IV, MD, Neel Desai, MD, Zaina Al-Mohtaseb, MD

Updates on Sjögren Syndrome

Stephen Pflugfelder, MD

Who Should Perform MIGS?

Osamah Saeedi, MD

Hot Topic: Technologies in 2018

Robert Weinstock, MD, Roger Zaldivar, MD

The Future of Cross-linking

William Trattler, MD

Should We Still Be Doing DSAEK?

Winston Chamberlain, MD, PhD

Hot Topic: Pharmaceutical Compounding

Keith Walter, MD, Nathan Radcliffe, MD, Tal Raviv, MD

Hot Topic: Successful Collaborations

Constance Okeke, MD, Greg Parkhurst, MD, John Berdahl, MD

Suprachoroidal Steroids for DME

Charles Wykoff, MD, PhD

Gene Therapy for Wet AMD

Szilárd Kiss, MD, examines gene therapy as a hot topic both in eye care and health care in general. Dr. Kiss notes the less-than-stellar results of three recent gene therapy studies for wet AMD, and he highlights important factors to consider in implementing the technique. He also discusses several promising preclinical programs and identifies an ongoing clinical trial with potential.

Posted: 11/17/2017


Please log in to leave a comment.

More From AAO: 2017 Coverage

Suprachoroidal Steroids for DME

Charles Wykoff, MD, PhD

Head-to-Head Trials

Pravin Dugel, MD